Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

July 14, 2009

Invest in Spain: Business Opportunities in the Biotechnology, Pharma and Life Sciences Sector

Speakers for this event:
  • Bárbara López Gómez, Investor Services Manager, INVEST IN SPAIN  Learn More
  • Jorge Arenas-Vidal, Director, BIOSERENTIA  Learn More
  • José Navas, Director, CARLOS III Health Institute  Learn More
  • Eduardo Bravo, CEO, CELLERIX  Learn More
  • Enrique Vázquez Tatay, CEO, NEOCODEX  Learn More
  • Invest in Spain: Business Opportunities in the Biotechnology, Pharma and Life Sciences Sector 

    The seminar will present the biotech and pharmaceutical sector in Spain and the investment opportunities that it offers.

    The participants to this seminar will find answers to the following questions:

    - Did you know that Spain is in the 4th position in Europe in scientific output in Biotechnology?

    - Did you know that in Spain you will find one of the most widely admired life science networks, combining hospitals, research centres and an excellent healthcare system?

    - Did you know that the number of new biotech companies in Spain increased by 166% from 2000 to 2006?

    - Did you know that Spain is highly competitive at a global level in Advanced Therapies?

    - Did you know that Cellerix is the first Spanish company with two orphan drugs approved by EMEA?

    • Presidents and CEOs
    • Vice Presidents
    • Business Development Managers
    • Medical Affairs Managers
    • Investment Managers

    From biotech and pharmaceutical companies, venture capital companies, start-up companies, research centres, scientific parks, and companies related to life sciences, seeking to set up or expand their business in Spain.


    Bárbara López Gómez, Investor Services Manager, INVEST IN SPAIN  

    Bárbara López Gómez holds a Biology degree from Complutense University of Madrid and both a Master degree in Management of Biotech Business (International School of Business ALITER, Madrid) and a Master degree in Project Management (La Salle University, Barcelona). Her professional focus is on biotech and life sciences project management, especially in public financing assessment. She has been actively involved in more than 60 public financing projects and served in companies as Oryzon Genomics, Alma Consulting Group and Medina, Terrón & Asociados.


    She is currently the Investor Services Manager at Invest in Spain for Biotech, Pharma and Life Sciences Sector.

    Jorge Arenas-Vidal, Director, BIOSERENTIA  

    Jorge is Founder and CEO of BioSerentia, a Business Accelerator for Life Sciences and Biotechnology Ventures and Projects.


    Jorge started his professional career in 1991 as a laboratory scientist and project leader in cellular toxicology and then moved to a strategic consulting position in the healthcare practice at Arthur Andersen. Five years later he founded the Biotechnology practice and held different managing positions at Stem SL, Vitalia SL and Blueline SL (lately merged) establishing new products and clients in the fields of healthcare, pharma and biotechnology, prior to founding BioSerentia as a business accelerator for life sciences ventures. He has represented Spain in the European Commission Group of Life Sciences Strategy for Competitiveness. He also serves in the Boards of Angiotheron Pharmaceuticals, SL and Pharmaceutical Management, SL. As a scientist, consultant, manager and entrepreneur, he has been working for governments, universities, research centers, entrepreneurs and investors for 15 years in Spain, the EU and the US.


    Jorge holds a PhD in Cellular Toxicology (magna cum laude) from the University of Navarra, and a Master in Bioscience Enterprise from Cambridge University & MIT. Distinguished by the Cambridge Entrepreneurship Centre (CEC) at Cambridge University.

    José Navas, Director, CARLOS III Health Institute  

    Born on January 10, 1948 in Melilla, he holds a doctor of medicine degree from the Universidad Complutense de Madrid (1981), having completed his residency in pathological anatomy at the Jiménez Díaz Foundation and Northwestern University’s Northwestern Memorial Hospital in Chicago (1971-1976).

    In the course of his teaching career, he has held the posts of professor of pathological anatomy at the Universidad Complutense de Madrid (1976-1984), professor of pathological anatomy at the Universidad Autónoma de Barcelona (1984-2008) and chair of the Board of Professors for the Inter-university Master’s in Science Leadership and Management (UAB-UB-PCB) (2007-2008).

    As part of his medical work, he has managed the Pathological Anatomy Section at 12 de Octubre Hospital and the Pathological Anatomy Department at Germans Trias i Pujol University Hospital (HUGTP in its Catalan acronym). As the person responsible for management, he has held the position of medical manager and (1985-1987) manager (1988-1997) at the HUGTP and director of the Hospital Division at the Catalan Institute of Health (ICS in its Catalan acronym) (1998-2002).

    In the area of research, he was involved in setting up the HUGTP’s Research Foundation (1995), He has been scientific director for the group ICS (2003-2004), director of the Science Policy Master Plan (2004-2006) and director of the Health Sciences Research and Innovation Program (2007-2008) for the Catalan Department of Health.

    Eduardo Bravo, CEO, CELLERIX  

    Eduardo has more than 18 years experience in the pharmaceutical industry. His professional career includes several senior management positions at Sanofi-Aventis, including Vice President for Latin America, where he was in charge of more than 2000 employees and oversaw sales of more than €1 billion. At Sanofi-Aventis he also held positions such as Marketing and Sales Manager for Europe and General Manager for Belgium. He also worked for 7 years in SmithKline Beecham in sales positions both nationally and internationally. Eduardo holds a degree in Business Administration and an MBA (INSEAD, Fontainebleau, France). In addition, Eduardo Bravo is a member of the Board of Directors of Cellerix.

    Enrique Vázquez Tatay, CEO, NEOCODEX  


    Enrique Vázquez Tatay, PhD, MBA cofounder and Chief Executive Officer (CEO) of NeoCodex. PhD in Pharmacy, in molecular and cellular biology, Dr. Vázquez completed his scientific formation with master degrees in economic and business management.


    Previously serving as Sales Director for Biomedal Inc., and as the Regional Director for Organon Española, Dr. Vázquez brings to NeoCodex a background of diverse cross-industrial experience. As a contributing author to many scientific books and publications, Dr. Vázquez also remains involved throughout the scientific community by teaching courses at the university, delivering lectures at countless conferences and seminars each year.


    Dr. Vázquez has provided the direction and leadership required for the continued growth and success of NeoCodex.


    INVEST IN SPAIN is the leading Government organization that supports foreign companies seeking to set up or expand their business in Spain. The organization provides comprehensive, efficient and confidential consultation at no cost during all stages of the investment process, from planning and evaluation, to start-up and post-investment services.

    The services include the provision of information, analysis and tailor-made reports on a wide range of topics including project costs, tax and incentives, administrative procedures, etc. The dedicated and professional guidance is guaranteed by assigning a project manager to the case who will become the long-term strategic partner.

    Being fully committed with the life sciences industry, INVEST IN SPAIN is focused on highlighting the strengths and encouraging the development of life sciences in Spain, working closely with the national network of regional promotion agencies and the main actors of the life sciences sector in Spain.

    For more information about Spain, visit www.investinspain.org/

    For information about the recorded archive for this event contact Xtalks at (416) 977-6555 ext 371, or email register@xtalks.com

    Copyright © 2016-2017 Honeycomb Worldwide Inc.